This report is being submitted retrospectively as part of internal review.The investigation analysis was performed on the user synced glucose data on data management system (dms), which is an eversense cloud platform.Based on the investigation analysis, the reported event could not be confirmed as there was no blood glucose (bg) or the calibration entry of 2.8 mmol/l at the time of event.The system was displaying 6 mmol/l at the time of event.The investigation analysis showed that sensor was still settling at the time of incident as it was inserted on (b)(6) 2023.Typically, in the first several days after the insertion, the wound healing response to the insertion site can lead to either a hinderance of the sensor's access to the glucose in the interstitial fluid or an initial depression of the optical signal, or both.This incident happened during initial settling period and once the sensor stabilized after insertion, the system started to perform within expectations.The current sensor performance is within expectations.No further investigation was found necessary for this complaint.
|